Risk factors for an atherothrombotic event in patients with diabetic macular edema treated with intravitreal injections of bevacizumab

AIM: To identify risk factors for an atherothrombotic event (ATE) among patients who were treated for diabetic macular edema (DME) with intravitreal bevacizumab injections. METHODS: This retrospective study enrolled all consecutive patients with DME who were treated by intravitreal bevacizumab from...

Full description

Bibliographic Details
Main Authors: Alon Tiosano, Aviel Hadad, Noam Yanculovic
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2020-09-01
Series:International Journal of Ophthalmology
Subjects:
Online Access:http://ies.ijo.cn/en_publish/2020/9/20200912.pdf